Sector pending / Electromedical and Electrotherapeutic ApparatusUpdated 2026-05-10 22:07 UTC

BCBA/MDT stock hub

BCBA/MDT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BCBA/MDTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

136.2T

Buenos Aires Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BCBA/MDT

In the news

Latest news · BCBA/MDT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13

P25 n/aP50 n/aP75 n/a

Trailing P/E20.6

P25 n/aP50 n/aP75 n/a

ROE9.4

P25 n/aP50 n/aP75 n/a

ROIC8

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BCBA/MDT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

USD

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Ireland
Country code	AR
Employees	95,000
Employees Change	0%
Employees Change Percent	0
Enterprise value	ARS 163.7T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Electromedical and Electrotherapeutic Apparatus
Last refreshed	2026-05-10
Market cap	ARS 136.2T
Price	ARS 28,260
Price currency	ARS
Rev Per Employee	534,575,797.89x
Sic	3845
Symbol	bcba/MDT
Website	https://www.medtronic.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.85%
EV Earnings	24.79x
EV/EBIT	17.73x
EV/EBITDA	12.07x
EV/FCF	21.14x
EV/Sales	3.31x
FCF yield	5.69%
Forward P/E	13.02x
P/B ratio	1.93x
P/E ratio	20.62x
P/S ratio	2.68x
PE Ratio10 Y	31x
PE Ratio3 Y	27.1x
PE Ratio5 Y	29.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.68%
EBITDA Margin	26.6%
FCF margin	15.25%
Gross margin	65.16%
Gross Profit	ARS 33.1T
Gross Profit Growth	6.18%
Gross Profit Growth Q	5.95%
Gross Profit Growth3 Y	4.04%
Gross Profit Growth5 Y	5.18%
Net Income	ARS 6.6T
Net Income Growth	8.29%
Net Income Growth Q	-11.67%
Net Income Growth3 Y	4.31%
Net Income Growth5 Y	9.79%
Pretax Margin	15.67%
Profit Margin	13%
Profit Per Employee	ARS 69.5M
ROA	4.57
Roa5y	4.21
ROCE	8.09
ROE	9.39
Roe5y	8.16
ROIC	7.98
Roic5y	7.52

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	18.99%
Cagr3y	42.8%
Cagr5y	43.51%
Div CAGR10	65.89%
Div CAGR3	105.35%
Div CAGR5	79.24%
EPS Growth	9.47
EPS Growth Q	-11.8
EPS Growth3 Y	5.55
EPS Growth5 Y	10.95
FCF Growth	-1.04%
FCF Growth Q	9.73%
FCF Growth3 Y	9.1%
FCF Growth5 Y	3.16%
OCF Growth	-0.11%
OCF Growth Q	6.69%
OCF Growth10 Y	2.3%
OCF Growth3 Y	8.93%
OCF Growth5 Y	4.15%
Revenue Growth	6.88x
Revenue Growth Q	8.74x
Revenue Growth3 Y	4.86x
Revenue Growth5 Y	4.91x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	ARS 0.39
Assets	ARS 130.9T
Cash	ARS 12T
Current Assets	ARS 33.7T
Current Liabilities	ARS 13.3T
Debt	ARS 40.2T
Debt EBITDA	ARS 2.88
Debt Equity	ARS 0.57
Debt FCF	ARS 5.19
Equity	ARS 70.4T
Interest Coverage	9.3
Liabilities	ARS 60.5T
Long Term Assets	ARS 97.3T
Long Term Liabilities	ARS 47.2T
Net Cash	ARS -28T
Net Cash By Market Cap	ARS -20.54
Net Debt EBITDA	ARS 2.07
Net Debt Equity	ARS 0.4
Net Debt FCF	ARS 3.61
Tangible Book Value	ARS -4.6T
Tangible Book Value Per Share	ARS -3,615

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.54
Inventory Turnover	2.07
Net Working Capital	ARS 9.1T
Quick ratio	1.55
Working Capital	ARS 20.9T
Working Capital Turnover	ARS 4,023

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.83%
Dividend Growth	36.23%
Dividend Growth Years	16%
Dividend per share	ARS 642
Dividend Years	27
Dividend Yield	2.27%
Ex Div Date	2026-03-27
Last Dividend	ARS 165
Payout Frequency	Quarterly
Payout Ratio	78.65%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	18.98%
200-day SMA	34,361.6
3Y total return	191.24%
50-day SMA	32,123.2
50-day SMA vs 200-day SMA	50under200
5Y total return	508.5%
All Time High	41,500
All Time High Change	-31.9%
All Time High Date	2025-11-27
All Time Low	2,171
All Time Low Change	1,201.7%
All Time Low Date	2019-12-16
ATR	678.6
Ch YTD	-23.08
High	29,100
High52	41,500
High52 Date	2025-11-27
High52ch	-31.9%
Low	28,220
Low52	23,150
Low52 Date	2025-05-23
Low52ch	22.07%
Ma50ch	-12.03%
Price vs 200-day SMA	-17.76%
RSI	29.76
RSI Monthly	49.64
RSI Weekly	29.55
Sharpe ratio	0.62x
Sortino ratio	1.08
Total Return	3.1%
Tr YTD	-22.49
Tr1m	-12.13%
Tr1w	-3.81%
Tr3m	-25.49%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	ARS 9.5T
Operating Income Growth	-1.3
Operating Income Growth Q	-0.88
Operating Income Growth3 Y	4.42
Operating Income Growth5 Y	11.22
Operating margin	18.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,281,569,053%
Net Borrowing	-1,412,644,496,170
Shares Insiders	0.04%
Shares Institutions	88.93%
Shares Qo Q	0.12%
Shares Yo Y	-0.83%
Short Ratio	1.75

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	ARS 7.1T
Average Volume	824.95x
Bv Per Share	54,627.7
CAPEX	ARS -2.7T
Ch1m	-12.13
Ch1w	-3.81
Ch1y	16.3
Ch3m	-26.06
Ch3y	175.7
Ch5y	465.2
Ch6m	-16.88
Change	-2.75%
Change From Open	-2.89
Close	29,060
Days Gap	0.14
Depreciation Amortization	3,930,228,746,770
Dollar Volume	35,522,820
Earnings Date	2026-06-03
EBIT	ARS 9.5T
EBITDA	ARS 13.5T
EPS	ARS 5,123
F Score	6
FCF	ARS 7.7T
FCF EV Yield	4.73x
Financing CF	-7,450,827,200,000
Fiscal Year End	April
Founded	1,949
Goodwill	58,592,577,458,964
Graham Number	21225.93216
Graham Upside	-24.89
Income Tax	ARS 1.3T
Investing CF	-3,588,018,400,000
Is Primary Listing	0
Last Report Date	2026-01-23
Last Split Date	2020-10-22
Last Split Type	Forward
Lynch Fair Value	ARS 13,413
Lynch Upside	-52.54
Ma150	35,359.7
Ma150ch	-20.08%
Ma20	30,607
Ma20ch	-7.67%
Net CF	-133,101,600,000
Next Earnings Date	2026-06-03
Open	29,100
P FCF Ratio	17.59
P OCF Ratio	13.06
Payment Date	2026-04-17
Position In Range	4.55
Ppne	10,040,965,186,143
Price Date	2026-05-08
Price EBITDA	ARS 10.08
Relative Volume	1.52x
Revenue	50,784,700,800,000x
SBC By Revenue	1.27x
Share Based Comp	645,471,200,000
Tax By Revenue	2.6x
Tax Rate	16.59%
Tr6m	-15.85%
Volume	1,257
Z Score	2.98

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BCBA/MDT dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.3%

$642 annual per share

Payout ratio

+78.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+79.2%

16 consecutive years of growth

Total shareholder yield

+3.1%

Next ex-dividend date: 2026-03-27

Performance

BCBA/MDT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BCBA/MDT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+88.9%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BCBA/MDT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.8

Below 30: short-term oversold

Price vs 200-day MA

-17.8%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.62

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BCBA/MDT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bcba/MDT stock rating?

bcba/MDT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bcba/MDT analysis?

The full report lives at /stocks/bcba/MDT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bcba/MDT?

The latest report frames bcba/MDT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bcba/MDT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.